<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Financial Outlook on FinanClub</title>
    <link>https://finan.club/tags/financial-outlook/</link>
    <description>Recent content in Financial Outlook on FinanClub</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Tue, 08 Aug 2023 06:46:20 +0000</lastBuildDate><atom:link href="https://finan.club/tags/financial-outlook/index.xml" rel="self" type="application/rss+xml" />
    <item>
      <title> BMY</title>
      <link>https://finan.club/us/bmy/</link>
      <pubDate>Tue, 08 Aug 2023 06:46:20 +0000</pubDate>
      
      <guid>https://finan.club/us/bmy/</guid>
      <description>score:972
Chances: Bristol Myers Squibb has a history of consistently paying dividends for the last 90 years. Pharmaceutical company AbbVie reports better-than-expected Q2 sales for its arthritis medication Humira. Discounted blue-chip stocks with potential upside may offer investment opportunities in a market with some lagging stocks.</description>
    </item>
    
    <item>
      <title> MRNA</title>
      <link>https://finan.club/us/mrna/</link>
      <pubDate>Tue, 08 Aug 2023 06:22:27 +0000</pubDate>
      
      <guid>https://finan.club/us/mrna/</guid>
      <description>score:1127
Chances: Moderna&amp;rsquo;s stock has reached a new 52-week low, with charts and indicators indicating a weak setup due to a downward trend. Despite market fluctuations, the value of Moderna&amp;rsquo;s stock is being assessed, considering its potential amidst challenges. Moderna&amp;rsquo;s Q2 2023 earnings call revealed a miss on earnings expectations, which could impact investor sentiment.</description>
    </item>
    
  </channel>
</rss>
